Turnout Raises $35 Million Series A to Put an AI Advocate in Every American’s Corner
Turnout has grown its client base fivefold since announcing its seed round in September 2025, logging more than ten million...
Disability
Personal Alarms Australia Launches Mobile 4G Devices for Emergency Support
Most falls occur in public spaces, but many detection systems work only within a small radius of the home. Personal...
Paralyzed Veterans of America Calls for Airlines to Fully Implement
Groundbreaking Disability Training as Landmark Rule Takes Effect June 17WASHINGTON, June 10, 2026 /PRNewswire/ -- After years of Paralyzed Veterans of...
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc...
Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees
New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa The IKEA Foundation has committed...
CONNECTA Therapeutics Initiates Phase IIa Clinical Trial of CTH120, a First-in-Class Neuroplasticity Modulator, in Fragile X Syndrome
Builds on positive Phase I safety data and represents a key value-inflection milestone for the CompanyAdvances a potentially disease-modifying approach...
Press Release: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today...
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement in MG-ADL observed in Phase...
Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy
– Successful End-of-Phase 2 meeting with FDA agreeing on key elements of the proposed Phase 3 design, including study population,...
National Action Urged to Address Chronic Pain Crisis Among Women and Women Veterans in Canada
HAMILTON, Ontario, June 08, 2026 (GLOBE NEWSWIRE) -- A newly released national report is calling for urgent, coordinated action to...
David Healy, President of Sun Life U.S., receives HELP Hero award from HELP USA
Recognition honors Sun Life's commitment to expanding health access through community-based investingWELLESLEY, Mass. and NEW YORK, June 4, 2026 /PRNewswire/...
NAELA Welcomes New Board Leadership for 2026-2027
VIENNA, Va., June 4, 2026 /PRNewswire/ -- The National Academy of Elder Law Attorneys (NAELA), the leading professional association dedicated...
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Designation is supported by an exploratory analysis from the Phase 1b study showing that some children with SMA previously treated...
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered...
Kyverna Therapeutics Highlights Updated Miv-cel Data at EULAR Demonstrating Substantial Reduction in Disease Activity in ACPA-Positive, Treatment Refractory Rheumatoid Arthritis
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36 Single-dose of miv-cel delivered...
TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)
Pharmacokinetic and pharmacodynamic data support quarterly subcutaneous BRIUMVI dosing regimen currently under evaluation in fully enrolled Phase 3 trial; Top-line...
NATIONAL MS SOCIETY, COMMUNITY PARTNERS SHOW EARLY IMPACT IN CLOSING MULTIPLE SCLEROSIS CARE GAPS IN SOUTH CAROLINA
Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward...
NATIONAL MS SOCIETY, COMMUNITY PARTNERS SHOW EARLY IMPACT IN CLOSING MULTIPLE SCLEROSIS CARE GAPS IN SOUTH CAROLINA
Partnerships with the Medical University of South Carolina, Prisma Health, and the South Carolina Community Health Worker Association drive toward...
Enlyte’s 2026 Envision Trends Report Explores Forces Driving Claim Complexity
Annual publication analyzes structural shifts reshaping claims management, includinglitigation, workforce transformation and evolving medical and vehicle challengesSAN DIEGO, June 2,...
From Fusion to Motion: Dr. Joel S. Beckett Presented Restorative Motion Surgery Concepts at the Hoag Orthopedic Institute Spine Symposium
Presentation explored motion-restoring alternatives for select patients with persistent pain or pseudoarthrosis following cervical fusion surgery BEVERLY HILLS, CA /...